<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are clonal <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> characterized by <z:hpo ids='HP_0001876'>pancytopenia</z:hpo>, dysplastic hematopoiesis, and a propensity to leukemic transformation </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0006042'>Increased apoptosis</z:mp> has been noted in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> as a possible explanation for ineffective hematopoiesis, with lower levels in progression to and in de novo <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> can be measured by binding of Annexin V to exposed membrane phosphatidylserine </plain></SENT>
<SENT sid="3" pm="."><plain>We postulated that the apoptotic index would aid in the differential diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> versus other hematopoietic diseases </plain></SENT>
<SENT sid="4" pm="."><plain>We examined 33 bone marrow aspirates suspected of <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancy</z:e> for apoptotic index by Annexin V analysis using a Becton Dickinson FACStar+ flow cytometer </plain></SENT>
<SENT sid="5" pm="."><plain>The apoptotic index was expressed as the percentage of Annexin V-positive cells divided by total mononuclear cells in the gate </plain></SENT>
<SENT sid="6" pm="."><plain>By standard morphologic analysis, 16 cases were diagnosed as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (9 <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> [RA], 2 <z:hpo ids='HP_0004828'>refractory anemia with ringed sideroblasts</z:hpo> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>], 1 <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>], 3 <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>], and 1 unclassified), 11 as <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (AL), 6 as <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>Eight cases (uninvolved marrow of five patients with <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> [LPD], one patient with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, and two patients with <z:hpo ids='HP_0001903'>anemia</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> disease) served as nonneoplastic controls </plain></SENT>
<SENT sid="8" pm="."><plain>A higher degree of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (mean = 44.7%; range = 29.5--60%) compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> (mean = 8.2%; range = 2.3--15.4%), AL (mean = 16.1%; range = 5.1--29.4%), and control marrow samples (mean = 11.6%; range = 1.5--21%) </plain></SENT>
<SENT sid="9" pm="."><plain>Additionally, the apoptotic index was significantly higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> (P &lt; 0.0001) </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, a high apoptotic index occurs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, supporting previous reports and suggesting that Annexin V analysis can be used as an adjunct in the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> versus <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>This would be particularly useful for the often-difficult distinction between early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> cases with equivocal <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
</text></document>